2003 Fiscal Year Final Research Report Summary
Studies on the transmission model for vivax malaria and its simulations
| Project/Area Number |
13640116
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
General mathematics (including Probability theory/Statistical mathematics)
|
|---|
| Research Institution | OKAYAMA UNIVERSITY |
|---|
Principal Investigator |
ISHIKAWA Hirofumi OKAYAMA UNIVERSITY, Environmental Sci. & Tech. & Environmental Math. Sci., Professor, 環境理工学部, 教授 (00108101)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SASAKI Toru Environmental Sci. & Tech. & Environmental Math. Sci., Lecturer, 環境理工学部, 講師 (20260664)
|
|---|
| Project Period (FY) |
2001 – 2003
|
| Keywords | Plasmodium vivax / Malaria / Transmission / The Solomon Islands / Model / Simulation / Relapse |
|---|
| Research Abstract |
We have proposed a mathematical model describing the transmission of Plasmodium vivax malaria quantitatively, which is adjusted to the infected region, Guadalcanal, in the Solomon Islands. The simulation of a transmission model will be instrumental in planning the malaria control strategy. A characteristic of the life cycle of P. vivax parasites is that a sporozoite injected into the blood stream by a mosquito bite may sometimes stay in a hepatocyte as a hypnozoite. Therefore we have incorporated a phenomenon of renewed infections caused by a relapse into the transmission model. Also through the simulations we have attempted to evaluate the decline in prevalence caused by the programs of selective mass drug administration (MDA) and vector control such as the distribution of permethrin-treated bednets. The simulations have indicated that the concentrated repetition of MDA at one week intervals would reduce the prevalence of vivax malaria swiftly in the beginning and would keep the parasite rate below 1% for a few years but the prevalence would increase thereafter. In contrast the parasite rate would remain below 1% for a long time if a trial of one or two times MDA is accompanied with some reduction of the vectorial capacity by the enforcement of vector control. In any case, it is important to beware of relapse cases because even after the execution of MDA it takes a long time to decrease the proportion of hypnozoite carriers.
|
